A network medicine approach maps aging hallmarks as interconnected molecular modules, enabling systematic identification of existing drugs that can modulate age-related transcriptional changes. This method shifts drug discovery from single-target approaches to interventions that address multiple aging pathways simultaneously.
Key Points
- Aging hallmarks form interconnected molecular modules in human interactome
- Existing drugs can be repurposed to influence aging transcription
- Network framework enables multi-pathway intervention strategy
Longevity Analysis
The interconnected nature of aging processes means single-intervention approaches often fail because they ignore compensatory mechanisms across systems. By mapping how aging hallmarks communicate through molecular networks, researchers can identify drugs already approved for other conditions that simultaneously modulate multiple age-related pathways—reducing development timelines and expanding the therapeutic toolkit. This approach acknowledges that energy production, regeneration, hormonal regulation, and defense systems do not operate independently; interventions must account for their interdependence to produce measurable longevity outcomes.
Original published by Nature Aging, by Bnaya Gross.